Generic Pharmasec enters into agreement with Abbott Point of Care

01 Jun 2021 Evaluate

Generic Pharmasec has entered into an agreement with Abbott Point of Care (APOC) Inc, the medical & diagnostics devices division of Abbott, for the distribution, marketing and promotion of the entire range of products by APOC in the entire country of India. The agreement has just now become effective and covers the entire length & breadth of the country.

The agreement will increase the annual diagnostic tests supplied by Generic Pharmasec by more than two-fold to an upwards of 1 million test annually. It will also improve the Product Margin on the Abbott Point of Care products by Generic Pharmasec by 2.5% which is almost 50% higher than current margins.

Generic Pharmasec will now increase its focus on creating high value propositions for all hospitals in India for all their Critical Diagnostic Requirements. To Increase the footprint in the country & improve access to Critical Diagnostic Solutions in Tier-2 & Tier-3 towns, Generic Pharmasec will appoint 15 new sub-distributors over the course of the next 24 months in such identified towns across the country.

Genpharmasec Share Price

3.39 -0.08 (-2.31%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sudarshan Chemicals 1130.35
Bodal Chemicals 69.83
Shree Pushkar Chem 351.95
Kiri Industries 658.80
Bhageria Industries 201.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.